APO Research
Talk to an analyst

APO RESEARCH · REPORT

Biodegradable Embolic Microspheres

Compare research editions
View pricing & licenses

Selected research

Industry Research

Biodegradable Embolic Microspheres Industry Research Report 2026

23 December 2025133 pages

Choose your research edition.

Industry ResearchBiodegradable Embolic Microspheres Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Biodegradable Embolic Microspheres Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Biodegradable Embolic Microspheres Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biodegradable Embolic Microspheres Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Biodegradable Embolic Microspheres Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global Biodegradable Embolic Microspheres market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Biodegradable Embolic Microspheres is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Biodegradable Embolic Microspheres is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Biodegradable Embolic Microspheres is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Biodegradable Embolic Microspheres include Varian, Jiangsu Hengrui Medicine, Terumo Corporation, Tepha, Teleflex, Promedics AG, Occlugel, Nippon Kayaku and Next Biomedical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Biodegradable Embolic Microspheres market in terms of revenue (US$ million) and, where applicable, sales volume (Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Tons) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Biodegradable Embolic Microspheres Market by Company

Varian

Jiangsu Hengrui Medicine

Terumo Corporation

Tepha

Teleflex

Promedics AG

Occlugel

Nippon Kayaku

Next Biomedical

Mermaid Medical

Merit Medical Systems

CeloNova BioSciences

BTG Corporate

Biosphere Medical

Biocompatibles

Angio Dynamics

ABK Biomedical

Biodegradable Embolic Microspheres Segment by Type

Visualization Type

Environmentally Responsive Type

Radioactive Type

Other

Biodegradable Embolic Microspheres Segment by Application

Research Institution

Hospitals And Clinics

Biodegradable Embolic Microspheres Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biodegradable Embolic Microspheres market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biodegradable Embolic Microspheres and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biodegradable Embolic Microspheres.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Biodegradable Embolic Microspheres manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Biodegradable Embolic Microspheres by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Biodegradable Embolic Microspheres in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Biodegradable Embolic Microspheres Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Biodegradable Embolic Microspheres Sales (Tons) of Manufacturers (2021-2026) Table 7. Global Biodegradable Embolic Microspheres Sales Market Share by Manufacturers (2021-2026) Table 8. Global Biodegradable Embolic Microspheres Revenue of Manufacturers (2021-2026) Table 9. Global Biodegradable Embolic Microspheres Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Biodegradable Embolic Microspheres Average Price (US$/Ton) of Manufacturers (2021-2026) Table 11. Global Biodegradable Embolic Microspheres Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Biodegradable Embolic Microspheres, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Biodegradable Embolic Microspheres, Product Type & Application Table 14. Global Biodegradable Embolic Microspheres Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Biodegradable Embolic Microspheres by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Varian Company Information Table 19. Varian Business Overview Table 20. Varian Biodegradable Embolic Microspheres Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 21. Varian Biodegradable Embolic Microspheres Product Portfolio Table 22. Varian Recent Developments Table 23. Jiangsu Hengrui Medicine Company Information Table 24. Jiangsu Hengrui Medicine Business Overview Table 25. Jiangsu Hengrui Medicine Biodegradable Embolic Microspheres Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 26. Jiangsu Hengrui Medicine Biodegradable Embolic Microspheres Product Portfolio Table 27. Jiangsu Hengrui Medicine Recent Developments Table 28. Terumo Corporation Company Information Table 29. Terumo Corporation Business Overview Table 30. Terumo Corporation Biodegradable Embolic Microspheres Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 31. Terumo Corporation Biodegradable Embolic Microspheres Product Portfolio Table 32. Terumo Corporation Recent Developments Table 33. Tepha Company Information Table 34. Tepha Business Overview Table 35. Tepha Biodegradable Embolic Microspheres Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 36. Tepha Biodegradable Embolic Microspheres Product Portfolio Table 37. Tepha Recent Developments Table 38. Teleflex Company Information Table 39. Teleflex Business Overview Table 40. Teleflex Biodegradable Embolic Microspheres Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 41. Teleflex Biodegradable Embolic Microspheres Product Portfolio Table 42. Teleflex Recent Developments Table 43. Promedics AG Company Information Table 44. Promedics AG Business Overview Table 45. Promedics AG Biodegradable Embolic Microspheres Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 46. Promedics AG Biodegradable Embolic Microspheres Product Portfolio Table 47. Promedics AG Recent Developments Table 48. Occlugel Company Information Table 49. Occlugel Business Overview Table 50. Occlugel Biodegradable Embolic Microspheres Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 51. Occlugel Biodegradable Embolic Microspheres Product Portfolio Table 52. Occlugel Recent Developments Table 53. Nippon Kayaku Company Information Table 54. Nippon Kayaku Business Overview Table 55. Nippon Kayaku Biodegradable Embolic Microspheres Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 56. Nippon Kayaku Biodegradable Embolic Microspheres Product Portfolio Table 57. Nippon Kayaku Recent Developments Table 58. Next Biomedical Company Information Table 59. Next Biomedical Business Overview Table 60. Next Biomedical Biodegradable Embolic Microspheres Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 61. Next Biomedical Biodegradable Embolic Microspheres Product Portfolio Table 62. Next Biomedical Recent Developments Table 63. Mermaid Medical Company Information Table 64. Mermaid Medical Business Overview Table 65. Mermaid Medical Biodegradable Embolic Microspheres Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 66. Mermaid Medical Biodegradable Embolic Microspheres Product Portfolio Table 67. Mermaid Medical Recent Developments Table 68. Merit Medical Systems Company Information Table 69. Merit Medical Systems Business Overview Table 70. Merit Medical Systems Biodegradable Embolic Microspheres Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 71. Merit Medical Systems Biodegradable Embolic Microspheres Product Portfolio Table 72. Merit Medical Systems Recent Developments Table 73. CeloNova BioSciences Company Information Table 74. CeloNova BioSciences Business Overview Table 75. CeloNova BioSciences Biodegradable Embolic Microspheres Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 76. CeloNova BioSciences Biodegradable Embolic Microspheres Product Portfolio Table 77. CeloNova BioSciences Recent Developments Table 78. BTG Corporate Company Information Table 79. BTG Corporate Business Overview Table 80. BTG Corporate Biodegradable Embolic Microspheres Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 81. BTG Corporate Biodegradable Embolic Microspheres Product Portfolio Table 82. BTG Corporate Recent Developments Table 83. Biosphere Medical Company Information Table 84. Biosphere Medical Business Overview Table 85. Biosphere Medical Biodegradable Embolic Microspheres Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 86. Biosphere Medical Biodegradable Embolic Microspheres Product Portfolio Table 87. Biosphere Medical Recent Developments Table 88. Biocompatibles Company Information Table 89. Biocompatibles Business Overview Table 90. Biocompatibles Biodegradable Embolic Microspheres Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 91. Biocompatibles Biodegradable Embolic Microspheres Product Portfolio Table 92. Biocompatibles Recent Developments Table 93. Angio Dynamics Company Information Table 94. Angio Dynamics Business Overview Table 95. Angio Dynamics Biodegradable Embolic Microspheres Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 96. Angio Dynamics Biodegradable Embolic Microspheres Product Portfolio Table 97. Angio Dynamics Recent Developments Table 98. ABK Biomedical Company Information Table 99. ABK Biomedical Business Overview Table 100. ABK Biomedical Biodegradable Embolic Microspheres Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 101. ABK Biomedical Biodegradable Embolic Microspheres Product Portfolio Table 102. ABK Biomedical Recent Developments Table 103. Global Biodegradable Embolic Microspheres Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 104. Global Biodegradable Embolic Microspheres Sales by Region (2021-2026) & (Tons) Table 105. Global Biodegradable Embolic Microspheres Sales Market Share by Region (2021-2026) Table 106. Global Biodegradable Embolic Microspheres Sales by Region (2027-2032) & (Tons) Table 107. Global Biodegradable Embolic Microspheres Sales Market Share by Region (2027-2032) Table 108. Global Biodegradable Embolic Microspheres Revenue by Region (2021-2026) & (US$ Million) Table 109. Global Biodegradable Embolic Microspheres Revenue Market Share by Region (2021-2026) Table 110. Global Biodegradable Embolic Microspheres Revenue by Region (2027-2032) & (US$ Million) Table 111. Global Biodegradable Embolic Microspheres Revenue Market Share by Region (2027-2032) Table 112. North America Biodegradable Embolic Microspheres Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. North America Biodegradable Embolic Microspheres Sales by Country (2021-2026) & (Tons) Table 114. North America Biodegradable Embolic Microspheres Sales by Country (2027-2032) & (Tons) Table 115. North America Biodegradable Embolic Microspheres Revenue by Country (2021-2026) & (US$ Million) Table 116. North America Biodegradable Embolic Microspheres Revenue by Country (2027-2032) & (US$ Million) Table 117. Europe Biodegradable Embolic Microspheres Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. Europe Biodegradable Embolic Microspheres Sales by Country (2021-2026) & (Tons) Table 119. Europe Biodegradable Embolic Microspheres Sales by Country (2027-2032) & (Tons) Table 120. Europe Biodegradable Embolic Microspheres Revenue by Country (2021-2026) & (US$ Million) Table 121. Europe Biodegradable Embolic Microspheres Revenue by Country (2027-2032) & (US$ Million) Table 122. Asia Pacific Biodegradable Embolic Microspheres Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. Asia Pacific Biodegradable Embolic Microspheres Sales by Country (2021-2026) & (Tons) Table 124. Asia Pacific Biodegradable Embolic Microspheres Sales by Country (2027-2032) & (Tons) Table 125. Asia Pacific Biodegradable Embolic Microspheres Revenue by Country (2021-2026) & (US$ Million) Table 126. Asia Pacific Biodegradable Embolic Microspheres Revenue by Country (2027-2032) & (US$ Million) Table 127. South America Biodegradable Embolic Microspheres Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. South America Biodegradable Embolic Microspheres Sales by Country (2021-2026) & (Tons) Table 129. South America Biodegradable Embolic Microspheres Sales by Country (2027-2032) & (Tons) Table 130. South America Biodegradable Embolic Microspheres Revenue by Country (2021-2026) & (US$ Million) Table 131. South America Biodegradable Embolic Microspheres Revenue by Country (2027-2032) & (US$ Million) Table 132. Middle East and Africa Biodegradable Embolic Microspheres Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. Middle East and Africa Biodegradable Embolic Microspheres Sales by Country (2021-2026) & (Tons) Table 134. Middle East and Africa Biodegradable Embolic Microspheres Sales by Country (2027-2032) & (Tons) Table 135. Middle East and Africa Biodegradable Embolic Microspheres Revenue by Country (2021-2026) & (US$ Million) Table 136. Middle East and Africa Biodegradable Embolic Microspheres Revenue by Country (2027-2032) & (US$ Million) Table 137. Global Biodegradable Embolic Microspheres Sales by Type (2021-2026) & (Tons) Table 138. Global Biodegradable Embolic Microspheres Sales by Type (2027-2032) & (Tons) Table 139. Global Biodegradable Embolic Microspheres Sales Market Share by Type (2021-2026) Table 140. Global Biodegradable Embolic Microspheres Sales Market Share by Type (2027-2032) Table 141. Global Biodegradable Embolic Microspheres Revenue by Type (2021-2026) & (US$ Million) Table 142. Global Biodegradable Embolic Microspheres Revenue by Type (2027-2032) & (US$ Million) Table 143. Global Biodegradable Embolic Microspheres Revenue Market Share by Type (2021-2026) Table 144. Global Biodegradable Embolic Microspheres Revenue Market Share by Type (2027-2032) Table 145. Global Biodegradable Embolic Microspheres Price by Type (2021-2026) & (US$/Ton) Table 146. Global Biodegradable Embolic Microspheres Price by Type (2027-2032) & (US$/Ton) Table 147. Global Biodegradable Embolic Microspheres Sales by Application (2021-2026) & (Tons) Table 148. Global Biodegradable Embolic Microspheres Sales by Application (2027-2032) & (Tons) Table 149. Global Biodegradable Embolic Microspheres Sales Market Share by Application (2021-2026) Table 150. Global Biodegradable Embolic Microspheres Sales Market Share by Application (2027-2032) Table 151. Global Biodegradable Embolic Microspheres Revenue by Application (2021-2026) & (US$ Million) Table 152. Global Biodegradable Embolic Microspheres Revenue by Application (2027-2032) & (US$ Million) Table 153. Global Biodegradable Embolic Microspheres Revenue Market Share by Application (2021-2026) Table 154. Global Biodegradable Embolic Microspheres Revenue Market Share by Application (2027-2032) Table 155. Global Biodegradable Embolic Microspheres Price by Application (2021-2026) & (US$/Ton) Table 156. Global Biodegradable Embolic Microspheres Price by Application (2027-2032) & (US$/Ton) Table 157. Key Raw Materials Table 158. Raw Materials Key Suppliers Table 159. Biodegradable Embolic Microspheres Distributors List Table 160. Biodegradable Embolic Microspheres Customers List Table 161. Biodegradable Embolic Microspheres Industry Trends Table 162. Biodegradable Embolic Microspheres Industry Drivers Table 163. Biodegradable Embolic Microspheres Industry Restraints Table 164. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Biodegradable Embolic Microspheres Product Image Figure 5. Global Biodegradable Embolic Microspheres Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Biodegradable Embolic Microspheres Market Size (2021-2032) & (US$ Million) Figure 7. Global Biodegradable Embolic Microspheres Sales (2021-2032) & (Tons) Figure 8. Global Biodegradable Embolic Microspheres Average Price (US$/Ton) & (2021-2032) Figure 9. Visualization Type Product Image Figure 10. Environmentally Responsive Type Product Image Figure 11. Radioactive Type Product Image Figure 12. Other Product Image Figure 13. Research Institution Product Image Figure 14. Hospitals And Clinics Product Image Figure 15. Global Biodegradable Embolic Microspheres Revenue Share by Manufacturers in 2025 Figure 16. Global Manufacturers of Biodegradable Embolic Microspheres, Manufacturing Sites & Headquarters Figure 17. Global Top 5 and 10 Biodegradable Embolic Microspheres Players Market Share by Revenue in 2025 Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Biodegradable Embolic Microspheres Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 20. Global Biodegradable Embolic Microspheres Sales by Region in 2025 Figure 21. Global Biodegradable Embolic Microspheres Revenue by Region in 2025 Figure 22. North America Biodegradable Embolic Microspheres Market Size by Country in 2025 Figure 23. North America Biodegradable Embolic Microspheres Sales Market Share by Country (2021-2032) Figure 24. North America Biodegradable Embolic Microspheres Revenue Market Share by Country (2021-2032) Figure 25. United States Biodegradable Embolic Microspheres Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Canada Biodegradable Embolic Microspheres Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Mexico Biodegradable Embolic Microspheres Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Europe Biodegradable Embolic Microspheres Market Size by Country in 2025 Figure 29. Europe Biodegradable Embolic Microspheres Sales Market Share by Country (2021-2032) Figure 30. Europe Biodegradable Embolic Microspheres Revenue Market Share by Country (2021-2032) Figure 31. Germany Biodegradable Embolic Microspheres Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. France Biodegradable Embolic Microspheres Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. U.K. Biodegradable Embolic Microspheres Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Italy Biodegradable Embolic Microspheres Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Russia Biodegradable Embolic Microspheres Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Spain Biodegradable Embolic Microspheres Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Netherlands Biodegradable Embolic Microspheres Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Switzerland Biodegradable Embolic Microspheres Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Sweden Biodegradable Embolic Microspheres Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Poland Biodegradable Embolic Microspheres Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Asia Pacific Biodegradable Embolic Microspheres Market Size by Country in 2025 Figure 42. Asia Pacific Biodegradable Embolic Microspheres Sales Market Share by Country (2021-2032) Figure 43. Asia Pacific Biodegradable Embolic Microspheres Revenue Market Share by Country (2021-2032) Figure 44. China Biodegradable Embolic Microspheres Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Japan Biodegradable Embolic Microspheres Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. South Korea Biodegradable Embolic Microspheres Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. India Biodegradable Embolic Microspheres Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Australia Biodegradable Embolic Microspheres Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Taiwan Biodegradable Embolic Microspheres Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Biodegradable Embolic Microspheres Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Southeast Asia Biodegradable Embolic Microspheres Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. South America Biodegradable Embolic Microspheres Market Size by Country in 2025 Figure 53. South America Biodegradable Embolic Microspheres Sales Market Share by Country (2021-2032) Figure 54. South America Biodegradable Embolic Microspheres Revenue Market Share by Country (2021-2032) Figure 55. Brazil Biodegradable Embolic Microspheres Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Argentina Biodegradable Embolic Microspheres Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Chile Biodegradable Embolic Microspheres Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Middle East and Africa Biodegradable Embolic Microspheres Market Size by Country in 2025 Figure 59. Middle East and Africa Biodegradable Embolic Microspheres Sales Market Share by Country (2021-2032) Figure 60. Middle East and Africa Biodegradable Embolic Microspheres Revenue Market Share by Country (2021-2032) Figure 61. Egypt Biodegradable Embolic Microspheres Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. South Africa Biodegradable Embolic Microspheres Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Israel Biodegradable Embolic Microspheres Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Türkiye Biodegradable Embolic Microspheres Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. GCC Countries Biodegradable Embolic Microspheres Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. Global Biodegradable Embolic Microspheres Sales Market Share by Type (2021-2032) Figure 67. Global Biodegradable Embolic Microspheres Revenue Market Share by Type (2021-2032) Figure 68. Global Biodegradable Embolic Microspheres Price (US$/Ton) by Type (2021-2032) Figure 69. Global Biodegradable Embolic Microspheres Sales Market Share by Application (2021-2032) Figure 70. Global Biodegradable Embolic Microspheres Revenue Market Share by Application (2021-2032) Figure 71. Global Biodegradable Embolic Microspheres Price (US$/Ton) by Application (2021-2032) Figure 72. Biodegradable Embolic Microspheres Value Chain Figure 73. Biodegradable Embolic Microspheres Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Biodegradable Embolic Microspheres Industry Opportunities and Challenges

Scope & coverage.

Types
  • Visualization Type
  • Environmentally Responsive Type
  • Radioactive Type
  • Other
Applications
  • Research Institution
  • Hospitals And Clinics
Companies covered
  • Varian
  • Jiangsu Hengrui Medicine
  • Terumo Corporation
  • Tepha
  • Teleflex
  • Promedics AG
  • Occlugel
  • Nippon Kayaku
  • Next Biomedical
  • Mermaid Medical
  • Merit Medical Systems
  • CeloNova BioSciences
  • BTG Corporate
  • Biosphere Medical
  • Biocompatibles
  • Angio Dynamics
  • ABK Biomedical

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Biodegradable Embolic Microspheres Market Size (2021-2032)
  4. 2.2.2 Global Biodegradable Embolic Microspheres Sales (2021-2032)
  5. 2.2.3 Global Biodegradable Embolic Microspheres Market Average Price (2021-2032)
  6. 2.3 Biodegradable Embolic Microspheres by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Visualization Type
  9. 2.3.3 Environmentally Responsive Type
  10. 2.3.4 Radioactive Type
  11. 2.3.5 Other
  12. 2.4 Biodegradable Embolic Microspheres by Application
  13. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  14. 2.4.2 Research Institution
  15. 2.4.3 Hospitals And Clinics
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Biodegradable Embolic Microspheres Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Biodegradable Embolic Microspheres Sales (Tons) of Manufacturers (2021-2026)
  3. 3.3 Global Biodegradable Embolic Microspheres Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Biodegradable Embolic Microspheres Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Biodegradable Embolic Microspheres Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Biodegradable Embolic Microspheres, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Biodegradable Embolic Microspheres, Product Type & Application
  8. 3.8 Global Manufacturers of Biodegradable Embolic Microspheres, Established Date
  9. 3.9 Global Biodegradable Embolic Microspheres Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Varian
  2. 4.1.1 Varian Company Information
  3. 4.1.2 Varian Business Overview
  4. 4.1.3 Varian Biodegradable Embolic Microspheres Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Varian Biodegradable Embolic Microspheres Product Portfolio
  6. 4.1.5 Varian Recent Developments
  7. 4.2 Jiangsu Hengrui Medicine
  8. 4.2.1 Jiangsu Hengrui Medicine Company Information
  9. 4.2.2 Jiangsu Hengrui Medicine Business Overview
  10. 4.2.3 Jiangsu Hengrui Medicine Biodegradable Embolic Microspheres Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Jiangsu Hengrui Medicine Biodegradable Embolic Microspheres Product Portfolio
  12. 4.2.5 Jiangsu Hengrui Medicine Recent Developments
  13. 4.3 Terumo Corporation
  14. 4.3.1 Terumo Corporation Company Information
  15. 4.3.2 Terumo Corporation Business Overview
  16. 4.3.3 Terumo Corporation Biodegradable Embolic Microspheres Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Terumo Corporation Biodegradable Embolic Microspheres Product Portfolio
  18. 4.3.5 Terumo Corporation Recent Developments
  19. 4.4 Tepha
  20. 4.4.1 Tepha Company Information
  21. 4.4.2 Tepha Business Overview
  22. 4.4.3 Tepha Biodegradable Embolic Microspheres Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Tepha Biodegradable Embolic Microspheres Product Portfolio
  24. 4.4.5 Tepha Recent Developments
  25. 4.5 Teleflex
  26. 4.5.1 Teleflex Company Information
  27. 4.5.2 Teleflex Business Overview
  28. 4.5.3 Teleflex Biodegradable Embolic Microspheres Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Teleflex Biodegradable Embolic Microspheres Product Portfolio
  30. 4.5.5 Teleflex Recent Developments
  31. 4.6 Promedics AG
  32. 4.6.1 Promedics AG Company Information
  33. 4.6.2 Promedics AG Business Overview
  34. 4.6.3 Promedics AG Biodegradable Embolic Microspheres Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Promedics AG Biodegradable Embolic Microspheres Product Portfolio
  36. 4.6.5 Promedics AG Recent Developments
  37. 4.7 Occlugel
  38. 4.7.1 Occlugel Company Information
  39. 4.7.2 Occlugel Business Overview
  40. 4.7.3 Occlugel Biodegradable Embolic Microspheres Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Occlugel Biodegradable Embolic Microspheres Product Portfolio
  42. 4.7.5 Occlugel Recent Developments
  43. 4.8 Nippon Kayaku
  44. 4.8.1 Nippon Kayaku Company Information
  45. 4.8.2 Nippon Kayaku Business Overview
  46. 4.8.3 Nippon Kayaku Biodegradable Embolic Microspheres Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Nippon Kayaku Biodegradable Embolic Microspheres Product Portfolio
  48. 4.8.5 Nippon Kayaku Recent Developments
  49. 4.9 Next Biomedical
  50. 4.9.1 Next Biomedical Company Information
  51. 4.9.2 Next Biomedical Business Overview
  52. 4.9.3 Next Biomedical Biodegradable Embolic Microspheres Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Next Biomedical Biodegradable Embolic Microspheres Product Portfolio
  54. 4.9.5 Next Biomedical Recent Developments
  55. 4.10 Mermaid Medical
  56. 4.10.1 Mermaid Medical Company Information
  57. 4.10.2 Mermaid Medical Business Overview
  58. 4.10.3 Mermaid Medical Biodegradable Embolic Microspheres Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Mermaid Medical Biodegradable Embolic Microspheres Product Portfolio
  60. 4.10.5 Mermaid Medical Recent Developments
  61. 4.11 Merit Medical Systems
  62. 4.11.1 Merit Medical Systems Company Information
  63. 4.11.2 Merit Medical Systems Business Overview
  64. 4.11.3 Merit Medical Systems Biodegradable Embolic Microspheres Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Merit Medical Systems Biodegradable Embolic Microspheres Product Portfolio
  66. 4.11.5 Merit Medical Systems Recent Developments
  67. 4.12 CeloNova BioSciences
  68. 4.12.1 CeloNova BioSciences Company Information
  69. 4.12.2 CeloNova BioSciences Business Overview
  70. 4.12.3 CeloNova BioSciences Biodegradable Embolic Microspheres Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 CeloNova BioSciences Biodegradable Embolic Microspheres Product Portfolio
  72. 4.12.5 CeloNova BioSciences Recent Developments
  73. 4.13 BTG Corporate
  74. 4.13.1 BTG Corporate Company Information
  75. 4.13.2 BTG Corporate Business Overview
  76. 4.13.3 BTG Corporate Biodegradable Embolic Microspheres Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 BTG Corporate Biodegradable Embolic Microspheres Product Portfolio
  78. 4.13.5 BTG Corporate Recent Developments
  79. 4.14 Biosphere Medical
  80. 4.14.1 Biosphere Medical Company Information
  81. 4.14.2 Biosphere Medical Business Overview
  82. 4.14.3 Biosphere Medical Biodegradable Embolic Microspheres Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Biosphere Medical Biodegradable Embolic Microspheres Product Portfolio
  84. 4.14.5 Biosphere Medical Recent Developments
  85. 4.15 Biocompatibles
  86. 4.15.1 Biocompatibles Company Information
  87. 4.15.2 Biocompatibles Business Overview
  88. 4.15.3 Biocompatibles Biodegradable Embolic Microspheres Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Biocompatibles Biodegradable Embolic Microspheres Product Portfolio
  90. 4.15.5 Biocompatibles Recent Developments
  91. 4.16 Angio Dynamics
  92. 4.16.1 Angio Dynamics Company Information
  93. 4.16.2 Angio Dynamics Business Overview
  94. 4.16.3 Angio Dynamics Biodegradable Embolic Microspheres Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Angio Dynamics Biodegradable Embolic Microspheres Product Portfolio
  96. 4.16.5 Angio Dynamics Recent Developments
  97. 4.17 ABK Biomedical
  98. 4.17.1 ABK Biomedical Company Information
  99. 4.17.2 ABK Biomedical Business Overview
  100. 4.17.3 ABK Biomedical Biodegradable Embolic Microspheres Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 ABK Biomedical Biodegradable Embolic Microspheres Product Portfolio
  102. 4.17.5 ABK Biomedical Recent Developments
5 Global Biodegradable Embolic Microspheres Market Scenario by Region
  1. 5.1 Global Biodegradable Embolic Microspheres Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Biodegradable Embolic Microspheres Sales by Region: 2021-2032
  3. 5.2.1 Global Biodegradable Embolic Microspheres Sales by Region: 2021-2026
  4. 5.2.2 Global Biodegradable Embolic Microspheres Sales by Region: 2027-2032
  5. 5.3 Global Biodegradable Embolic Microspheres Revenue by Region: 2021-2032
  6. 5.3.1 Global Biodegradable Embolic Microspheres Revenue by Region: 2021-2026
  7. 5.3.2 Global Biodegradable Embolic Microspheres Revenue by Region: 2027-2032
  8. 5.4 North America Biodegradable Embolic Microspheres Market Facts & Figures by Country
  9. 5.4.1 North America Biodegradable Embolic Microspheres Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Biodegradable Embolic Microspheres Sales by Country (2021-2032)
  11. 5.4.3 North America Biodegradable Embolic Microspheres Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Biodegradable Embolic Microspheres Market Facts & Figures by Country
  16. 5.5.1 Europe Biodegradable Embolic Microspheres Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Biodegradable Embolic Microspheres Sales by Country (2021-2032)
  18. 5.5.3 Europe Biodegradable Embolic Microspheres Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Biodegradable Embolic Microspheres Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Biodegradable Embolic Microspheres Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Biodegradable Embolic Microspheres Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Biodegradable Embolic Microspheres Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Biodegradable Embolic Microspheres Market Facts & Figures by Country
  41. 5.7.1 South America Biodegradable Embolic Microspheres Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Biodegradable Embolic Microspheres Sales by Country (2021-2032)
  43. 5.7.3 South America Biodegradable Embolic Microspheres Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Biodegradable Embolic Microspheres Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Biodegradable Embolic Microspheres Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Biodegradable Embolic Microspheres Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Biodegradable Embolic Microspheres Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Biodegradable Embolic Microspheres Sales by Type (2021-2032)
  2. 6.1.1 Global Biodegradable Embolic Microspheres Sales by Type (2021-2032) & (Tons)
  3. 6.1.2 Global Biodegradable Embolic Microspheres Sales Market Share by Type (2021-2032)
  4. 6.2 Global Biodegradable Embolic Microspheres Revenue by Type (2021-2032)
  5. 6.2.1 Global Biodegradable Embolic Microspheres Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Biodegradable Embolic Microspheres Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Biodegradable Embolic Microspheres Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Biodegradable Embolic Microspheres Sales by Application (2021-2032)
  2. 7.1.1 Global Biodegradable Embolic Microspheres Sales by Application (2021-2032) & (Tons)
  3. 7.1.2 Global Biodegradable Embolic Microspheres Sales Market Share by Application (2021-2032)
  4. 7.2 Global Biodegradable Embolic Microspheres Revenue by Application (2021-2032)
  5. 7.2.1 Global Biodegradable Embolic Microspheres Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Biodegradable Embolic Microspheres Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Biodegradable Embolic Microspheres Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Biodegradable Embolic Microspheres Value Chain Analysis
  2. 8.1.1 Biodegradable Embolic Microspheres Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Biodegradable Embolic Microspheres Production Mode & Process
  5. 8.2 Biodegradable Embolic Microspheres Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Biodegradable Embolic Microspheres Distributors
  8. 8.2.3 Biodegradable Embolic Microspheres Customers
9 Global Biodegradable Embolic Microspheres Analyzing Market Dynamics
  1. 9.1 Biodegradable Embolic Microspheres Industry Trends
  2. 9.2 Biodegradable Embolic Microspheres Industry Drivers
  3. 9.3 Biodegradable Embolic Microspheres Industry Opportunities and Challenges
  4. 9.4 Biodegradable Embolic Microspheres Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst